Attendee Breakdown

Join leaders developing oligonucleotide therapies for CNS disorders to discuss delivery, targeting, and clinical translation, and connect with peers across biotech, pharma, and academia working to move the field forward.

Explore the full breakdown and see who's in the room.

Companies in Attendance

Aarhus University · AbbVie · Advirna · Alnylam Pharmaceuticals · Aperture Therapeutics · Atalanta Therapeutics · Atlas Ventures · Avidity Biosciences, Inc. · Biogen · BioMarin Pharmaceutical · Bonito Biosciences Inc. · CAMP4 Therapeutics · Celanese · Creative BioLabs · Creyon Bio · D2B3, Inc. · Dyne Therapeutics · Entrada Therapeutics Inc. · ExRNA Therapeutics · Fuku Biotech · GATEHOUSE BIO · GondolaBio · Grünenthal · Institut de recherches cliniques de Montréal · Leal Therapeutics · Nanocarry · Neurvati Neurosciences · Neurocrine Biosciences · Nissan Chemical America Corporation · Northeastern University · NS Pharma, Inc. · Ophidion, Inc. · Opprtna Therapeutics · Peritia · ProteinQure · QurAlis Corp. · Quiver Bioscience · Regeneron Pharmaceuticals · Riboway Therapeutics · Roche · Sanofi · Simcere Pharmaceutical Groups · Stoke Therapeutics Inc. · Trace Neuroscience · University of Massachusetts Medical School · University of Pennsylvania · University of Ulm · Valaya Bio

Job Titles Represented

C-Suite / Founder

Chief Executive Officer · CEO · Chief Executive Officer & Founder · Chief Executive Officer & Chief Scientific Officer · Co-Founder & Chief Executive Officer · Founder & Chief Executive Officer · Chief Innovation & Scientific Officer · Chief Managing Director · Chief Medical Officer · Chief Scientific Officer · Chief Technology Officer

Senior Leadership

Senior Vice President · Senior Vice President & Head of Technology · Senior Vice President of Drug Discovery · Senior Vice President, Translational DMPK & Clinical Pharmacology · SVP Business Development · Vice President · Vice President & Head of Neuroscience · Vice President & Head of Oligonucleotide Therapeutics · Vice President, Research & Development

Director Level

Associate Director, BD & Ops · Director · Director CNS · Director - Drug Metabolism & Pharmacokinetics · Director Neuroscience Research · Director, Neurobiology · Director, Neuromuscular Research · Director, Oligonucleotide Chemistry · Director, Translational Medicine · Scientific Director · Scientific Director, Biologics Drug Discovery · Senior Director NGTz · Senior Director, New Modalities · Senior Director, Pain & Therapeutics Lead

Head Of / Lab Head

Head of Drug Development · Head of Innovation Research Partnering · Head Of Gene & Protein Modulation Lab, Discovery Biology · Neuroscientist & Head of PRIME RNA Neurosciences

Principal / Lead Scientists

Principal Research Scientist · Principal Scientist · Principle Associate

Scientists (Mid-Level & Senior ICs)

Scientist · Senior Scientist · Senior Scientist DMPK · Senior Scientist I · Senior Scientist II, CNS Discovery

Academia / Research

PhD Candidate, Bioengineering · Professor · Postdoc · Postdoctoral Associate · Postdoctoral Fellow · Research Assistant Professor · Researcher

67550 - attendee breakdown

Explore the Full Event Guide

Discover three days of highly technical, data‑driven discussions tackling the most pressing challenges in CNS drug development.

What you’ll find inside:

  • Full expert speaker faculty
  • Sessions featuring brand‑new data
  • Unmissable workshop sessions
  • Insight into dedicated networking opportunities
  • A breakdown of expected audience

Your definitive guide - share with your team to assess relevance and mobilize internal interest.

6th Oligonucleotides for CNS Summit 2026 Brochure